Answer
Dovato is not recommended with emtricitabine-containing medicines because lamivudine in Dovato and emtricitabine are both cytidine analogues, creating a risk of intracellular interactions.
Sources for this answer
- Dovato 50 mg/300 mg film-coated tabletsViiV Healthcare UK Ltd · emc · SmPC §4.5 Interaction with other medicinal products · Version 17Document updated
Sources checked